NCT02159547View on ClinicalTrials.gov

IV Dexketoprofen vs Placebo in Migranie Attack

PHASE4CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Migraine
Interventions
DRUG

Dexketoprofen

50 mg intravenous arveles in 50 ml saline in 5 minutes

OTHER

Normal Saline

50 ml normal saline

Trial Locations (1)

Unknown

Antalya Training and Govermental Hospital, Antalya

All Listed Sponsors
lead

Akdeniz University

OTHER

NCT02159547 - IV Dexketoprofen vs Placebo in Migranie Attack | Biotech Hunter | Biotech Hunter